News
-
-
-
-
-
-
PRESS RELEASE
EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future
EssilorLuxottica and Meta showcase new AI glasses at Meta Connect, including Oakley Meta Vanguard for athletes, Ray-Ban Meta Gen 2 with extended battery life, and Meta Ray-Ban Display with integrated display -
-
-
-
PRESS RELEASE
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
Nanobiotix announces new results from a Phase 1 study evaluating JNJ-1900 (NBTXR3) in combination with immune checkpoint inhibitors as a 2L+ therapy for patients with primary cutaneous melanoma resistant to anti-PD-1. Favorable safety profile and early efficacy signals observed
